UNH
UNH
UnitedHealth Group Incorporated
$401.03
-$0.13 (-0.03%)
Mkt Cap: $364.19B
Home / UNH / News

$16.35 EPS Masks a Sweeping Restructuring Year at Scale (UNH Q4 2025 Earnings Call)

By Dr. Graph | Updated on Apr 10, 2026 | earnings

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

UnitedHealth Group delivered a fiscal 2025 that paired steady execution against its long-term strategy with a sweeping internal restructuring designed to reset the foundation for multi-year earnings recovery. The company reported adjusted earnings per share of $16.35, slightly ahead of expectations, while absorbing a $1.6 billion net charge principally tied to restructuring Optum's portfolio. Management guided 2026 adjusted EPS to greater than $17.75, representing at least 8.6% growth, as margin recovery across UnitedHealthcare and operational improvements within Optum begin to compound.

Revenue Hits $448B as Medical Care Ratio Lands Below Expectations

UnitedHealth Group generated full-year revenues of nearly $448 billion, reflecting 12% growth driven by domestic membership expansion of over 415,000 people. The full-year medical care ratio of 89.1% came in slightly better than expectations, though it included approximately 20 basis points of negative impact from charge-related items. The operating cost ratio of 13.3% was slightly elevated due to 40 basis points of charge impacts, including $800 million in broad-based employee incentives and UnitedHealth Foundation funding. Cash flows reached $19.7 billion, approximately 1.5 times net income. The $1.6 billion net charge comprised three components: $800 million for cyber attack-related collection true-ups, a $440 million net gain from portfolio optimization, and $2.5 billion in broad restructuring including a $625 million lost contract reserve for structurally unprofitable third-party relationships.

2026 Guidance Targets $17.75+ EPS with UHC Leading the Recovery

Management set 2026 revenue expectations at approximately $440 billion with adjusted EPS of greater than $17.75. UnitedHealthcare expects roughly 13% adjusted operating earnings growth, principally from commercial and Medicare margin improvement, expanding operating margins by 40 basis points. Tim Noel confirmed Medicare Advantage membership contraction of 1.3 to 1.4 million members for 2026, greater than originally anticipated due to competitive dynamics during the annual enrollment period, but consistent with a deliberate strategy that favored margin recovery. Medicare margins are expected to improve approximately 50 basis points from 2025. Noel called the 2027 advance notice "disappointing," warning it represents a third consecutive year of funding reductions totaling $130 billion and risks "profoundly negative" impacts on seniors' benefits and access.

OptumHealth Narrows Its Network by 20% to Rebuild Value-Based Care

Optum enters 2026 projecting adjusted earnings growth across all three segments, ranging from low to high single digits with margin expansion of 20 to 90 basis points. OptumHealth made the most dramatic changes, narrowing its affiliated provider network by nearly 20%, streamlining risk membership by approximately 15%, and consolidating from 18 electronic medical record systems down to three. CEO Patrick Conway described a "back to basics" focus on integrated value-based care, noting that practices operating in the fully integrated model drive total cost of care down by up to 30% with patient satisfaction NPS near 90. Management realigned Optum Financial Services into OptumInsight to combine healthcare technology and fintech capabilities, targeting real-time point-of-care approval and monetization.

OptumRx Wins 800 New Clients on Transparency Pivot

OptumRx delivered a strong external selling season, implementing and expanding over 800 new customer relationships. The segment offset UnitedHealthcare membership contraction by backfilling more than half of the lost volume. Over 95% of OptumRx customers elected full rebate pass-through in 2026, with all remaining customers expected to transition by 2027. The business removed reauthorization requirements for over 180 drugs, reducing overall prior authorization volume by 10%. CFO Wayne DeVeydt confirmed roughly two-thirds of full-year earnings will be generated in the first half, consistent with 2025 seasonality, driven by Part D benefit design changes under the Inflation Reduction Act.

Disclaimer: This report is for informational purposes only and does not constitute financial or investment advice. Always conduct your own research or consult a qualified professional before investing. Past performance is not indicative of future results.

Frequently Asked Questions

What drove the $1.6 billion restructuring charge in Q4 2025?
The charge comprised three components: approximately $800 million for cyber attack-related collection true-ups on provider loans, a net gain of $440 million from portfolio optimization of divested assets, and $2.5 billion in broad restructuring including $625 million for a lost contract reserve on structurally unprofitable third-party relationships that could not be exited for 2026.
How much Medicare Advantage membership contraction does UnitedHealth expect in 2026?
Tim Noel confirmed expected MA contraction of 1.3 to 1.4 million members for the full year across group, individual, and dual special needs plans. The losses exceeded original estimates due to competitive dynamics during the annual enrollment period, but management stated this was consistent with its margin recovery strategy.
What operational changes has OptumHealth made to improve performance?
OptumHealth narrowed its affiliated provider network by nearly 20%, streamlined risk membership by approximately 15%, consolidated from 18 electronic medical record systems to three, and refocused on integrated value-based care where fully aligned practices deliver 30% lower total cost of care with patient NPS near 90.
How is OptumRx addressing pharmacy transparency and affordability?
OptumRx committed to passing through 100% of drug rebates by 2027, with over 95% of customers already electing full pass-through in 2026. The business removed reauthorization for 180+ drugs and delivers over $2,200 in annual prescription cost savings per member through manufacturer price moderation efforts.

More from UNH

earnings

Q1 Margin Outperformance Meets $1.5B AI Modernization Drive (UNH Q1 2026 Earnings Call)

UnitedHealth Group delivered a robust first quarter, surpassing internal plans across all major segments and raising its full-year earnings outlook to greater than $18.25 per share. The results reflect disciplined pricing and early returns on structural operational improvements, alongside a massive $1.5 billion commitment to AI-driven modernization designed to permanently lower administrative burdens.

risk

DOJ Probe and CMS Rate Shock: Structural Risks Mount for UnitedHealth

UnitedHealth Group is facing a dual threat from escalating federal scrutiny and tightening reimbursement policies that challenge its vertically integrated business model. With a sweeping Department of Justice antitrust investigation and a near-flat Medicare Advantage rate proposal from CMS, the managed care giant must navigate a painful structural reset that includes aggressively shedding unprofitable demographics and absorbing multibillion-dollar restructuring charges.